Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Extension Study Evaluating the Long-Term Safety of ICA-17043 With or Without Hydroxyurea Therapy in Subjects With Sickle Cell Disease

NCT00294541 is registered in ClinicalTrials.gov with Icagen as lead sponsor.

NCT NCT00294541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00294541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Extension Study Evaluating the Long-Term Safety of ICA-17043 With or Without Hydroxyurea Therapy in Subjects With Sickle Cell Disease
Lead sponsor
Icagen
Phase
Phase 3
Overall status
Terminated
Start date
February 28, 2006
Completion date
June 30, 2007
Enrollment
51 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell anemia, sickle cell disease